BeOne Medicines Ltd. (ONC) › Shareholders' EquityBeOne Medicines Ltd. (ONC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2014: -$53.04M2015: -$101.77M2016: $352.91M2017: $669.81M2018: $1.74B2019: $962.21M2020: $3.87B2021: $6.13B2022: $4.38B2023: $3.54B2024: $3.33B2025: $4.36B$4.36B2014Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$4.36B+30.9%2024$3.33B-5.8%2023$3.54B-19.3%2022$4.38B-28.5%2021$6.13B+58.5%2020$3.87B+302.1%2019$962.21M-44.7%2018$1.74B+159.7%2017$669.81M+89.8%2016$352.91M+446.8%2015-$101.77M-91.9%2014-$53.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share